Fate Therapeutics
Clinical trials sponsored by Fate Therapeutics, explained in plain language.
-
New 'Off-the-Shelf' cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new cancer treatment called FT825, a type of CAR T-cell therapy that is made from donor cells and does not need to be personalized. It is given with or without additional antibody drugs to people with advanced solid tumors that have HER2 or other ma…
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Off-the-Shelf cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new cancer treatment called FT836, a ready-made immune cell therapy, in people with advanced solid tumors like lung, colorectal, breast, ovarian, endometrial, or head and neck cancers. The treatment is given alone or with chemotherapy and/or antibod…
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated May 07, 2026 18:40 UTC